The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPetroTal Regulatory News (PTAL)

Share Price Information for PetroTal (PTAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 47.50
Bid: 47.00
Ask: 48.00
Change: 0.20 (0.42%)
Spread: 1.00 (2.128%)
Open: 47.50
High: 47.50
Low: 47.50
Prev. Close: 47.30
PTAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Warrants and TVR

22 Feb 2021 12:00

RNS Number : 9086P
PetroTal Corp.
22 February 2021
 

 

 

PetroTal announces Exercise of Warrants and TVR

 

Calgary, AB and Houston, TX - February 22, 2021 - PetroTal Corp. ("PetroTal" or the "Company") (TSX‐V: TAL and AIM: PTAL) announces that it received a notice to exercise warrants over 500,000 Common Shares at a price of 16 pence per Common Share (the "Warrant Exercise") on February 18, 2021 from an investor in relation to the Investor Warrants issued on June 12, 2020 in accordance with a Common Share equity issue on June 12, 2020. Accordingly, PetroTal received GBP80,000 in respect of this Warrant Exercise and issued 500,000 new Common Shares ("Warrant Shares") to the investor. Subsequent to this Warrant Exercise, the Company will have 70,101,946 Investor Warrants in issue.

Application will be made for admission of the 500,000 Warrant Shares, which will rank pari passu with existing Common Shares, to trading on AIM ("Admission"). It is expected that Admission will become effective and trading will commence at 8.00 a.m. on March 1, 2021.

Following Admission, the Company will have 816,667,379 Common Shares in issue and there are no shares held in treasury. This figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change of their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

ABOUT PETROTAL

 

PetroTal is a publicly traded, dual‐quoted (TSXV: TAL and AIM: PTAL) oil and gas development and production company domiciled in Calgary, Alberta, focused on the development of oil assets in Peru. PetroTal's flagship asset is its 100% working interest in Bretana oil field in Peru's Block 95 where oil production was initiated in June 2018, and in early 2020 became the second largest crude oil producer in Peru. Additionally, the Company has large exploration prospects and is engaged in finding a partner to drill the Osheki prospect in Block 107. The Company's management team has significant experience in developing and exploring for oil in Northern Peru and is led by a Board of Directors that is focused on safely and cost effectively developing the Bretana oil field.

 

For further information, please see the Company's website at www.petrotal-corp.com, the Company's filed documents at www.sedar.com, or contact:

 

Douglas Urch

Executive Vice President and Chief Financial Officer

Durch@PetroTal-Corp.com

T: (713) 609-9101

 

Manuel Pablo Zuniga-Pflucker

President and Chief Executive Officer

Mzuniga@PetroTal-Corp.com

T: (713) 609-9101

 

 

Celicourt Communications

Mark Antelme / Jimmy Lea

petrotal@celicourt.uk

T: 44 (0) 208 434 2643

 

Strand Hanson Limited (Nominated & Financial Adviser)

James Spinney / Ritchie Balmer

T: 44 (0) 207 409 3494

 

Stifel Nicolaus Europe Limited (Joint Broker)

Callum Stewart / Simon Mensley / Ashton Clanfield

Tel: +44 (0) 20 7710 7600

 

Auctus Advisors LLP (Joint Broker)

Jonathan Wright / Rupert Holdsworth Hunt / Harry Baker

T: +44 (0) 7711 627449

 

READER ADVISORIES

 

FORWARD‐LOOKING STATEMENTS: This press release contains certain statements that may be deemed to be forward‐looking statements.  Such statements relate to possible future events, including, but not limited to: PetroTal's business strategy, objectives, strength and focus; the Company's ability to operate in accordance with developing public health efforts to contain COVID-19; the timing of filing the Interim Filings. All statements other than statements of historical fact may be forward‐looking statements. Forward‐ looking statements are often, but not always, identified by the use of words such as "anticipate", "believe", "expect", "plan", "estimate", "potential", "will", "should", "continue", "may", "objective" and similar expressions. The forward‐looking statements are based on certain key expectations and assumptions made by the Company. Although the Company believes that the expectations and assumptions on which the forward‐looking statements are based are reasonable, undue reliance should not be placed on the forward‐looking statements because the Company can give no assurance that they will prove to be correct. Since forward‐looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties.  Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, risks associated with the oil and gas industry in general (e. g. , operational risks in development, exploration and production; delays or changes in plans with respect to exploration or development projects or capital expenditures; the uncertainty of reserve estimates; the uncertainty of estimates and projections relating to production, costs and expenses; and health, safety and environmental risks), commodity price and exchange rate fluctuations, legal, political and economic instability in Peru, access to transportation routes and markets for the Company's production, changes in legislation affecting the oil and gas industry and uncertainties resulting from potential delays or changes in plans with respect to exploration or development projects or capital expenditures.  In addition, the Company cautions that current global uncertainty with respect to the spread of the COVID-19 virus and its effect on the broader global economy may have a significant negative effect on the Company. While the precise impact of the COVID-19 virus on the Company remains unknown, rapid spread of the COVID-19 virus may continue to have a material adverse effect on global economic activity, and may continue to result in volatility and disruption to global supply chains, operations, mobility of people and the financial markets, which could affect interest rates, credit ratings, credit risk, inflation, business, financial conditions, results of operations and other factors relevant to the Company. Please refer to the risk factors identified in the Company's annual information form and management's discussion and analysis for the year ended December 31, 2019 which are available on SEDAR at www.sedar.com. The forward‐looking statements contained in this press release are made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward‐looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.

 

 

 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSDKBBPDBKDABB
Date   Source Headline
30th May 20237:02 amRNSTransaction in Own Shares
30th May 20237:00 amRNSSocial Fund By-laws Approved by Committee
26th May 20237:00 amRNSTransaction in Own Shares
25th May 20237:15 amRNSTransaction in Own Shares
24th May 20234:30 pmRNSHolding(s) in Company
24th May 20234:30 pmRNSHolding(s) in Company
24th May 20237:00 amRNSTransaction in Own Shares
23rd May 20237:00 amRNSTransaction in Own Shares
16th May 20237:00 amRNSCommencement of Share Buyback & Dividend Timetable
11th May 20237:00 amRNSQ1 2023 Financial and Operating Results
2nd May 20237:00 amRNSManagement Appointment
25th Apr 20237:00 amRNSQ1 2023 Operations and Liquidity Update
6th Apr 20237:00 amRNS2023 Grant of Performance Share Units
30th Mar 202311:05 amRNSSecond Price Monitoring Extn
30th Mar 202311:00 amRNSPrice Monitoring Extension
30th Mar 20237:00 amRNS2022 Year-End Financial and Operating Results
9th Mar 20237:00 amRNSPetroTal Announces Operations Update
3rd Mar 20237:00 amRNSExercise of Warrants & Total Voting Rights
14th Feb 20237:00 amRNSGraduation to The Toronto Stock Exchange
3rd Feb 20237:00 amRNSExercise of Warrants & Total Voting Rights
1st Feb 20237:00 amRNSIncreases in 2022 Year-End Oil Reserves
26th Jan 20237:00 amRNSSecond Annual ESG Report
23rd Jan 20237:00 amRNSExercise of Warrants and Total Voting Rights
16th Jan 20237:00 amRNS2023 Capital Investment Budget of US$125 million
3rd Jan 20237:00 amRNSNotice of Investor Event
28th Dec 20227:00 amRNSInitial Production for Well 12H and Other Updates
20th Dec 20227:00 amRNSWarrant Exercises and Total Voting Rights
15th Dec 202211:05 amRNSSecond Price Monitoring Extn
15th Dec 202211:00 amRNSPrice Monitoring Extension
15th Dec 20227:00 amRNSCorporate Update Regarding River Access
9th Dec 20227:00 amRNSPetroTal Issues Various Corporate Updates
28th Nov 20227:00 amRNSExercise of Warrants and Total Voting Rights
17th Nov 20227:00 amRNSQ3 2022 Financial and Operating Results
3rd Nov 20227:00 amRNSRobust Initial Production For Well 13H
13th Oct 20227:00 amRNSQ3 2022 Operations and Liquidity Update
10th Oct 20225:25 pmRNSExercise of Warrants and Total Voting Rights
20th Sep 20227:00 amRNSResults of Shareholders’ Meeting
7th Sep 20227:00 amRNSAdditional Director Nominees & Retirements
25th Aug 20227:00 amRNSQ2 2022 Financial and Operating Results
10th Aug 20229:07 amRNSExercise of Performance Warrants and TVR
25th Jul 20226:21 pmRNSExercise of Warrants and Total Voting Rights
12th Jul 20226:00 pmRNSHolding(s) in Company
12th Jul 20227:00 amRNSTR-1
12th Jul 20227:00 amRNSTR-1
11th Jul 20227:00 amRNSDirector Dealing
7th Jul 20227:00 amRNSGrant of Performance Share Units
5th Jul 20224:41 pmRNSSecond Price Monitoring Extn
5th Jul 20224:36 pmRNSPrice Monitoring Extension
5th Jul 20227:00 amRNSQ2 2022 Operations and Liquidity Update
4th Jul 20227:00 amRNSInvestor Warrants & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.